UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
CMRA holding history
Comera Life Sciences Holdings, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CMRA overviewAll 13F holders of CMRAFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −8,017−100.0% | Sold out | Holders |
| Q3 2023 | 8,017 | $2.33K | <0.1% | +6,366+385.6% | Added | Holders |
| Q2 2023 | 1,651 | $804 | <0.1% | −408−19.8% | Reduced | Holders |
| Q1 2023 | 2,059 | $1.85K | <0.1% | +826+67.0% | Added | Holders |
| Q4 2022 | 1,233 | $1.52K | <0.1% | −1,394−53.1% | Reduced | Holders |
| Q3 2022 | 2,627 | $4.00K | <0.1% | −535−16.9% | Reduced | Holders |
| Q2 2022 | 3,162 | $8.00K | <0.1% | +3,162 | New | Holders |